The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Advances in the prevention of Alzheimer's disease and dementia
Open accessAbstract
Background: Definitions and diagnostic criteria for all medical conditions are regularly subjected to reviews and revisions as knowledge advances. In the field of Alzheimer's disease (AD) research, it has taken almost three decades for diagnostic nomenclature to undergo major re‐examination. The shift towards presymptomatic and pre‐dementia stages of AD has brought prevention and treatment trials much closer to each other than before. Methods: Here we discuss: (i) the impact of diagnostic reliability on the possibilities for developing preventive strategies for AD; (ii) the scientific evidence to support moving from observation to action; (iii) ongoing intervention studies; and (iv) the methodological issues and prospects for balancing strategies for high‐risk individuals with those for broad population‐based prevention. Results: The associations between neuropathology and cognition are still not entirely clear. In addition, the risk factors for AD dementia and the neuropathological hallmarks of AD may not necessarily be the same. Cognitive impairment has a clearer clinical significance and should therefore remain the main focus of prevention. Risk/protective factors for dementia/AD need to be studied from a life‐course perspective. New approaches in prevention trials include enrichment strategies based on genetic risk factors or beta‐amyloid biomarkers (at least four ongoing pharmacological trials), and multidomain interventions simultaneously targeting various vascular and lifestyle‐related risk factors (at least three ongoing trials). Experience from prevention programmes in other chronic diseases can provide additional methodological improvements. Conclusions: Building infrastructures for international collaborations is necessary for managing the worldwide public health problem of AD and dementia. The International Database on Aging and Dementia (IDAD) and the European Dementia Prevention Initiative (EDPI) are examples of ongoing international efforts aiming to improve the methodology of preventive studies and provide the basis for larger intervention trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationThe Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citation
Research works printed but not linked: 4
- Williams JW, 2010, Preventing Alzheimer's Disease and Cognitive Decline. Evidence Report/Technology Assessment No. 193. (Prepared by the Duke Evidence‐Based Practice Center Under Contract No. HHSA 290‐2007‐10066‐I.)
- Rothman KJ, 2008, Causation and Causal Inference Modern Epidemiology, 5
- RosesAD Welsh‐BohmerKA BurnsDKet al.A Pharmacogenetics‐Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease 5th Conference Clinical Trials on Alzheimer's Disease.Monte Carlo:The Journal of Nutrition Health & Aging 2012;841.
- 10.1007/s12603-013-0004-0 · doi:10.1007/s12603-013-0004-0
Cited by
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationDefeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Self-citationLifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173
Self-citationMatthews, K. A., Xu, W., Gaglioti, A. H., Holt, J. B., Croft, J. B., Mack, D., & McGuire, L. C. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3063 · Cited by 1,124
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019
Li, X., Feng, X., Sun, X., Hou, N., Han, F., & Liu, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.937486 · Cited by 703
Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12191 · Cited by 651
Self-citationOn the path to 2025: understanding the Alzheimer’s disease continuum
Aisen, P. S., Cummings, J., Jack, C. R., Morris, J. C., Sperling, R., Frölich, L., Jones, R. W., Dowsett, S. A., Matthews, B. R., Raskin, J., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0283-5 · Cited by 556
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
A major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 398
Self-citationBrain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference
Morley, J. E., Morris, J. C., Berg-Weger, M., Borson, S., Carpenter, B. D., del Campo, N., Dubois, B., Fargo, K., Fitten, L. J., Flaherty, J. H., et al. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.06.017 · Cited by 328
Rosenberg, A., Mangialasche, F., Ngandu, T., Solomon, A., & Kivipelto, M. (2020) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2019.41 · Cited by 316
Self-citationKuiper, J. S., Zuidersma, M., Zuidema, S. U., Burgerhof, J. G. M., Stolk, R. P., Oude Voshaar, R. C., & Smidt, N. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw089 · Cited by 301
Kryscio, R. J., Abner, E. L., Caban-Holt, A., Lovell, M., Goodman, P., Darke, A. K., Yee, M., Crowley, J., & Schmitt, F. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5778 · Cited by 295
Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240
Prevention of dementia in an ageing world: Evidence and biological rationale
Grande, G., Qiu, C., & Fratiglioni, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101045 · Cited by 229
Self-citationMorris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Hölscher, C. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1738383 · Cited by 180
Vascular factors and multiple measures of early brain health: CARDIA brain MRI study
Launer, L. J., Lewis, C. E., Schreiner, P. J., Sidney, S., Battapady, H., Jacobs, D. R., Lim, K. O., D’Esposito, M., Zhang, Q., Reis, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122138 · Cited by 130
Multi-domain interventions for the prevention of dementia and cognitive decline
Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013572.pub2 · Cited by 124
Self-citationLong-term dementia risk prediction by the LIBRA score: a 30-year follow-up of the CAIDE study
Deckers, K., Barbera, M., Köhler, S., Ngandu, T., van Boxtel, M., Rusanen, M., Laatikainen, T., Verhey, F., Soininen, H., Kivipelto, M., et al. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5235 · Cited by 99
Self-citationEvaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer’s Disease
Chouraki, V., for the International Genomics of Alzheimer’s Project, Reitz, C., Maury, F., Bis, J. C., Bellenguez, C., Yu, L., Jakobsdottir, J., Mukherjee, S., Adams, H. H., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150749 · Cited by 98
Self-citationWang, J., Sun, B.-L., Xiang, Y., Tian, D.-Y., Zhu, C., Li, W.-W., Liu, Y.-H., Bu, X.-L., Shen, L.-L., Jin, W.-S., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00918-y · Cited by 87
Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults
Flatt, J. D., Johnson, J. K., Karpiak, S. E., Seidel, L., Larson, B., & Brennan-Ing, M. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171061 · Cited by 83
Frisoni, G. B., Molinuevo, J. L., Altomare, D., Carrera, E., Barkhof, F., Berkhof, J., Delrieu, J., Dubois, B., Kivipelto, M., Nordberg, A., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12132 · Cited by 78
Self-citationCavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack Jr, C. R., Sperling, R., Cummings, J., Blennow, K., et al. (2014) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2014.32 · Cited by 67
Self-citationCued memory decline in biomarker-defined preclinical Alzheimer disease
Papp, K. V., Rentz, D. M., Mormino, E. C., Schultz, A. P., Amariglio, R. E., Quiroz, Y., Johnson, K. A., & Sperling, R. A. (2017) · Neurology · doi:10.1212/wnl.0000000000003812 · Cited by 52
Parial, L. L., Lam, S. C., Ho, J. Y. S., Suen, L. K. P., & Leung, A. Y. M. (2021) · Aging & Mental Health · doi:10.1080/13607863.2020.1786801 · Cited by 43
Sex/gender and socioeconomic differences in modifiable risk factors for dementia
Geraets, A. F. J., & Leist, A. K. (2023) · Scientific Reports · doi:10.1038/s41598-022-27368-4 · Cited by 43
Panza, F., Seripa, D., Lozupone, M., Solfrizzi, V., Imbimbo, B. P., Barulli, M. R., Tortelli, R., Capozzo, R., Bisceglia, P., Dimitri, A., et al. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1389885 · Cited by 41
Public knowledge of late-life cognitive decline and dementia in an international sample
Van Patten, R., & Tremont, G. (2020) · Dementia · doi:10.1177/1471301218805923 · Cited by 40
Implementing the Proclamation of Stroke and Potentially Preventable Dementias
Hachinski, V., Ganten, D., Lackland, D., Kreutz, R., Tsioufis, K., & Hacke, W. (2018) · International Journal of Stroke · doi:10.1177/1747493018799965 · Cited by 18
Han, F., Xu, H., Shen, J.-X., Pan, C., Yu, Z.-H., Chen, J.-J., Zhu, X.-L., Cai, Y.-F., & Lu, Y.-P. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-021 · Cited by 18
de Krom, F. J. W., Sivananthan, S., Alkhotany, F., Celen, M., Hol, I. E., Houben, K. J. G., Sivananthan, P., Koekebakker, H., & Deckers, K. (2021) · Journal of Public Health Research · doi:10.4081/jphr.2021.1961 · Cited by 16
Feldman, H. H., & Estabrooks, C. A. (2017) · Canadian Journal of Public Health · doi:10.17269/cjph.108.5852 · Cited by 17
The impact of a national public awareness campaign on dementia knowledge and help-seeking in Ireland
Hickey, D., Glynn, R. W., Shelley, E., & Lawlor, B. (2019) · European Journal of Public Health · doi:10.1093/eurpub/ckz185.637 · Cited by 13
Metadata
- Authors
- Solomon, A., Mangialasche, F., Richard, E., Andrieu, S., Bennett, D. A., Breteler, M., Fratiglioni, L., Hooshmand, B., Khachaturian, A. S., Schneider, L. S., Skoog, I., & Kivipelto, M.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2014-03
- Volume
- 275
- Issue
- 3
- Pages
- 229-250
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2043715766
- Cited by
- 319
- References
- 102
- FWCI
- 25.38
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- NIH (P50 AG05142, R01 AG033288, R01 AG037561)
- Baxter
- Genentech
- Johnson & Johnson
- Eli Lilly
- Lundbeck
- Novartis
- Pfizer
- TauRx
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.